New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.
about
Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis.Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascitesPredictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review.Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.
P2860
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New model for end stage liver ...... rahepatic portosystemic shunt.
@en
New model for end stage liver ...... rahepatic portosystemic shunt.
@nl
type
label
New model for end stage liver ...... rahepatic portosystemic shunt.
@en
New model for end stage liver ...... rahepatic portosystemic shunt.
@nl
prefLabel
New model for end stage liver ...... rahepatic portosystemic shunt.
@en
New model for end stage liver ...... rahepatic portosystemic shunt.
@nl
P2093
P2860
P1476
New model for end stage liver ...... trahepatic portosystemic shunt
@en
P2093
Jennifer Guy
Ma Somsouk
Robert Kerlan
Scott W Biggins
Stephen Shiboski
P2860
P304
P356
10.1016/J.CGH.2009.06.009
P407
P50
P577
2009-06-26T00:00:00Z